2-(2,2-difluorobenzo[d][1,3]dioxol-5-ylamino)-N-(3-methylisoxazol-5-yl)acetamide

ID: ALA4163380

Chembl Id: CHEMBL4163380

PubChem CID: 51112335

Max Phase: Preclinical

Molecular Formula: C13H11F2N3O4

Molecular Weight: 311.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(NC(=O)CNc2ccc3c(c2)OC(F)(F)O3)on1

Standard InChI:  InChI=1S/C13H11F2N3O4/c1-7-4-12(22-18-7)17-11(19)6-16-8-2-3-9-10(5-8)21-13(14,15)20-9/h2-5,16H,6H2,1H3,(H,17,19)

Standard InChI Key:  MHXPARNUWACDCB-UHFFFAOYSA-N

Associated Targets(Human)

ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptor (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 311.24Molecular Weight (Monoisotopic): 311.0718AlogP: 2.36#Rotatable Bonds: 4
Polar Surface Area: 85.62Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.57CX Basic pKa: 2.59CX LogP: 1.96CX LogD: 1.75
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.90Np Likeness Score: -2.18

References

1. Paz OS, de Jesus Pinheiro M, do Espirito Santo RF, Villarreal CF, Castilho MS..  (2017)  Nanomolar anti-sickling compounds identified by ligand-based pharmacophore approach.,  136  [PMID:28528302] [10.1016/j.ejmech.2017.05.035]

Source